Building a Nomogram for Prediction of Prostate Cancer in Patients With Preoperatively Suspected Prostate Cancer
Yen‐Chuan Ou(Tungs' Taichung MetroHarbor Hospital), Tang‐Yi Tsao(Tungs' Taichung MetroHarbor Hospital), I‐Ju Tsai(China Medical University), Li‐Hua Huang(Zhujiang Hospital), Min‐Che Tung(National Chung Hsing University), Wei‐Chun Weng(Mackay Junior College of Medicine, Nursing and Management), Yi‐Sheng Lin(Peking University), Chao‐Yu Hsu(National Chung Hsing University), KUANGH-HSI CHANG(National United University)
Cited by 8
Related Papers
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial
|The Lancet Oncology|2020|502
Outcome of Surgery for Clinical Unilateral T3a Prostate Cancer: A Single-Institution Experience
|European Urology|2006|176
Outcome Predictors of Radical Prostatectomy in Patients With Prostate-Specific Antigen Greater Than 20 ng/ml: A European Multi-Institutional Study of 712 Patients
|European Urology|2010|154
Pathological results and rates of treatment failure in high‐risk prostate cancer patients after radical prostatectomy
|British Journal of Urology|2010|141